Atopix Therapeutics Limited was acquired by Chiesi Farmaceutici S.p.A. in November 2016 (see press release) and as a result the Atopix office in the UK will close on 28th June 2019.

Ongoing activites will be managed by Chiesi and all enquiries should be directed to Chiesi Farmaceutici S.p.A.

Atopix Tax Strategy (PDF 97kb)